Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_assertion type Assertion NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_head.
- NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_assertion description "[The haplotype analysis suggested that the TGA (VEGF -460/-1154/-2578) and CGA haplotypes exhibited a significant decrease in the risk of developing adenomyosis compared with the haplotype of TGC (OR = 0.64, 95% CI = 0.41-1.00; OR = 0.44, 95% CI = 0.21-0.93, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_provenance.
- NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_assertion evidence source_evidence_literature NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_provenance.
- NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_assertion SIO_000772 19197986 NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_provenance.
- NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_assertion wasDerivedFrom befree-20140225 NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_provenance.
- NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_assertion wasGeneratedBy ECO_0000203 NP623059.RAhmei-kCc1nLk1zNr6_MbdzEBm5_oxnhcZ-kJ-hXCgK4130_provenance.